Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CalciMedica Inc CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous (IV) formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase 2b trial (called CARPO - NCT04681066) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase 1/2 asparaginase induced pancreatic toxicity (AIPT) study (called CRSPA - NCT04195347).


NDAQ:CALC - Post by User

Post by alphaflighton Mar 11, 2021 9:52am
440 Views
Post# 32771501

Graycliff Commences Phase 2 Exploration at Shakespeare Gold

Graycliff Commences Phase 2 Exploration at Shakespeare Gold
 
Graycliff Exploration Commences
Phase Two of Exploration at
Shakespeare Gold Project
TORONTO, ON - March 11, 2021 -  Graycliff Exploration Limited (the “Company” or “Graycliff”) (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) is pleased to announce that drilling has resumed as part of phase two of the 2020/2021 exploration program at the Company’s Shakespeare Gold Project (“Shakespeare”) located on the prolific Canadian Shield near Sudbury, Ontario.
 
The Company is awaiting assay results from the final three holes from the Phase 1 drill program, which extended the previously identified mineralization and resulted in the discovery of a new mineralized zone.
 
Phase 2 Exploration Highlights:
  • The first round of 2021 core drilling will be 1,000 metres (“m”) with an average hole length of 150 m.
  • Drilling is continuing to focus on the mineralized zone area in the vicinity of the Miller Shaft, in order to provide the Company with a much more comprehensive understanding of structural and geological controls that affect the distribution of the gold mineralization.
  • Following the receipt of the Phase 2 assay data on these new holes, Graycliff will be carrying out 3D modelling of the interpreted structure and gold mineralization.
 
“We are extremely motivated by the success of the Phase 1 drilling program, which saw Shakespeare’s mineralized area expanded and directed us to earmark more drilling in the vicinity of the Miller Shaft and the Number 3 adit.  We are working in the ‘shadow of a historic headframe’, deemed often to be the best place to find a new gold mine,” stated Graycliff’s Technical Advisor and Qualified Person, Bruce Durham. Our expectation is that we will complete 1,000 m of additional drilling prior to Spring break-up at site. We are drilling below and along trend of the gold mineralization first discovered more than a century ago, and by the end of March we will be in a position to create a modern 3D model of the known geology and mineralization on the property that will draw on all of the available data.”
 
Qualified Person
Bruce Durham, P.Geo, is a Qualified Person, as that term is defined by Canadian regulatory guidelines under NI 43-101, and has read and approved the technical information contained in this press release. All information other than the results of the two new drill holes are historical in nature and while deemed relevant, should not be relied upon.
About Graycliff Exploration Limited.
Graycliff Exploration is a mineral exploration company focused on its 847 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of 39 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907. 
For more information, contact investor relations at investors@graycliffexploration.com
 
On Behalf of the Board of Directors,
 
James Macintosh
President and CEO
 
 
<< Previous
Bullboard Posts
Next >>